Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C40H59NO11
CAS Number:
Molecular Weight:
729.90
NACRES:
NA.21
Quality Level
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
General description
Eribulin is a synthetic analog of Halichondrin B, a compound isolated from the sea sponge Halichondria okadai.
Application
Eribulin may be used for investigating its effects on tumor microenvironment and tumor vasculature.
Biochem/physiol Actions
Eribulin is a microtubule dynamics inhibitor that results in prolonged mitotic arrest and subsequent apoptosis. It suppresses microtubule dynamic instability at plus ends through an inhibition of microtubule growth with little or no effect on shortening. Eribulin displays anticancer activity by inhibiting the proliferation of multiple cancer cell types.
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 2 - Muta. 2 - Repr. 2
Storage Class
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Javier Cortes et al.
Cancer treatment reviews, 70, 190-198 (2018-09-23)
Eribulin mesylate (eribulin) is a synthetic analogue of the marine-sponge natural product halichondrin B. Eribulin exhibits potent antiproliferative activities against a variety of human cancer cell types in vitro and in vivo, and is used for the treatment of certain
Ornella Garrone et al.
Future oncology (London, England), 13(30), 2759-2769 (2017-12-09)
Eribulin is a synthetic analog of halichondrin B belonging to microtubule-targeted agents with a distinct mechanism of inhibition of microtubule dynamics. This molecule has multiple nonmitotic effects on tumor biology, exhibiting effects on epithelial-mesenchimal transition and tumor vasculature. We review
Panagiotis Koliou et al.
Cancer management and research, 10, 207-216 (2018-02-15)
Eribulin mesylate is a synthetic derivative of halichondrin B isolated from a marine sponge. Its mechanism of action is through microtubule inhibition, which is different from that of taxanes. Eribulin has been approved for the treatment of metastatic breast cancer
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service